Effects of formoterol and budesonide on GM-CSF and IL-8 secretion by triggered human bronchial epithelial cells Source: Eur Respir J 2001; 17: 1070-1077 Year: 2001
Effects of formoterol and salmeterol on the production of Th1- and Th2-related chemokines by monocytes and bronchial epithelial cells Source: Eur Respir J 2008; 31: 1313-1321 Year: 2008
Synergistic anti-inflammatory effects of salmeterol and fluticasone on the release of IL-8 and MCP-1 by human bronchial epithelial cells Source: Eur Respir J 2003; 22: Suppl. 45, 39s Year: 2003
Complementary effects on IL-1, IL-6, TNF-alpha of salmeterol and/or montelukast added to fluticasone in moderate asthmatics Source: Eur Respir J 2004; 24: Suppl. 48, 580s Year: 2004
Formoterol but not salmeterol enhances cytokine release Source: Eur Respir J 2002; 20: Suppl. 38, 619s Year: 2002
Possible anti-inflammatory effect of salmeterol against interleukin-8 and neutrophil activation in asthma in vivo Source: Eur Respir J 2003; 21: 994-999 Year: 2003
The inhibitory effect of formoterol and salmeterol on the IP-10 (CXCL10) in bronchial epithelial cells Source: Annual Congress 2009 - Models of chronic airways disease and therapy Year: 2009
Cigarette smoke-induced IL-8 production by human monocyte-derived macrophages: synergistic inhibition by fluticasone and salmeterol Source: Eur Respir J 2005; 26: Suppl. 49, 14s Year: 2005
Combination of budesonide and formoterol is more effective in inhibiting GM-CSF production by bronchial epithelial cells than either drug alone Source: Eur Respir J 2003; 22: Suppl. 45, 457s Year: 2003
Formoterol and salmeterol enhance cytokine release in primary bronchial epithelial cells Source: Eur Respir J 2004; 24: Suppl. 48, 101s Year: 2004
Regulation of cytokine expression in human plasmacytoid dendritic cells by prostaglandin I2 analogues Source: Eur Respir J 2009; 33: 405-410 Year: 2009
Ketotifen induces primary necrosis in eosinophils Source: Eur Respir J 2004; 24: Suppl. 48, 36s Year: 2004
Cytokines in asthma Source: Eur Respir J 2001; 18: 24S-33S Year: 2001
Tiotropium enhances the inhibitory effect of the long acting β2-agonist olodaterol on the release of IL-6 and IL8 by primary human lung fibroblasts of asthma patients Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD Year: 2012
Inhibition of IL-8 and RANTES release from cultured human airway smooth muscle cells by fluticasone and budesonide Source: Eur Respir J 2002; 20: Suppl. 38, 384s Year: 2002
Inhibitory activity of mometasone furoate and dexamethasone on ICAM-1 expression and eotaxin, IL-6 and MCP-1 release by human foetal lung fibroblasts induced by TNF-α Source: Eur Respir J 2001; 18: Suppl. 33, 406s Year: 2001
Suppressive effects of formoterol and salmeterol on eotaxin-1 in bronchial epithelial cells Source: Annual Congress 2008 - Novel therapeutic approaches and immunological mechanisms in airway cell pathobiology Year: 2008
Effects of fluticasone and salmeterol on cytokine-induced airway smooth muscle IP10 release Source: Eur Respir J 2005; 26: Suppl. 49, 712s Year: 2005
Differences in efficacy between formoterol and salmeterol in relaxation of the mouse trachea are accentuated by inflammatory cytokines Source: Eur Respir J 2005; 26: Suppl. 49, 370s Year: 2005
Formoterol protects against platelet-activating factor-induced effects in asthma Source: Eur Respir J 2004; 23: 71-75 Year: 2004